CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives


Autoria(s): Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew
Data(s)

2014

Formato

application/pdf

Identificador

http://boris.unibe.ch/67475/1/Seiten_a45_a46_aus%20A1.full.pdf

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage

doi:10.7892/boris.67475

urn:issn:2050-6406

Idioma(s)

eng

Publicador

Sage

Relação

http://boris.unibe.ch/67475/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, F.; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-selectin) shedding for assessment of functional blockade of TNF alpha in anti-TNF treated IBD patients: clinical feasibility and perspectives. United European Gastroenterology Journal, 2(1suppl), A45-A46. Sage

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/conferenceObject

info:eu-repo/semantics/publishedVersion

PeerReviewed